AgomAb CEO Tim Jasper Knotnerus buys $94,880 of common shares

PUBT · 2d ago
AgomAb CEO Tim Jasper Knotnerus buys $94,880 of common shares
  • Agomab Therapeutics CEO Tim Jasper Knotnerus bought 11,000 common shares in open-market purchases priced at USD 8.48–8.70.
  • Directly held stake rose to 21,823 common shares following the transactions.
  • Separately, 34,394 common shares were reported as indirectly held through TJK Life Sciences B.V.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Agomab Therapeutics NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002120886-26-000001), on October 07, 2026, and is solely responsible for the information contained therein.